Hôpital Femme-Enfant-Adolescent

corporate_fareorganization

Hôpital Femme-Enfant-Adolescent

- Funding / Projects
  (9)

9 Projects, page 1 of 2

Anti-infectious agent specificity of benign (MGUS) and malignant (myeloma) monoclonal gammopathies: a proof-of-principle study.
assignment_turned_inProject2010 - 2012Partners:CHU, ORGANISME NON ASSOCIE, CHU Nantes - Hôtel Dieu, Institut de Biologie de Nantes, Hôpital Femme-Enfant-Adolescent
CHU,
ORGANISME NON ASSOCIE,
CHU Nantes - Hôtel Dieu,
Institut de Biologie de Nantes,
Hôpital Femme-Enfant-Adolescent
Funder: Institut National du Cancer Project Code: INCa-2641
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
more_vert
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
Immunotherapy with CD19ζ gene-modified EBV-specific CTLs after stem cell transplant in children with high-risk acute lymphoblastic leukaemia
assignment_turned_inProject2009 - 2012Partners:Centre Léon Bérard, CHU, Institut de Biologie de Nantes, Hôpital Femme-Enfant-Adolescent, Réseau Mélanome Ouest
Centre Léon Bérard,
CHU,
Institut de Biologie de Nantes,
Hôpital Femme-Enfant-Adolescent,
Réseau Mélanome Ouest
Funder: Institut National du Cancer Project Code: INCa-1458
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
more_vert
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
CALL-FB 01 : Protocole Franco-Belge de traitement des Leucémies Aiguës Lymphoblastiques de l’Enfant et de l’Adolescent CALL-FB 01: Franco-Belgian protocol for the treatment of acute lymphoblastic leukaemia (ALL) in children and adolescents
assignment_turned_inProjectPartners:Hôpital Saint-Louis, Hôpital des Enfants, Université de Bordeaux, Hôpital Debrousse, CHU Marseille - Hôpital la Timone +5 partners
Hôpital Saint-Louis,
Hôpital des Enfants,
Université de Bordeaux,
Hôpital Debrousse,
CHU Marseille - Hôpital la Timone,
Hôpital Jeanne de Flandre,
Hôpitaux de Brabois Adultes-Enfants,
Hôpital Robert Debré,
Groupe Hospitalier Armand Trousseau - Roche Guyon,
Hôpital Femme-Enfant-Adolescent
Funder: Institut National du Cancer Project Code: INCa-DGOS-2420
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
more_vert
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
Etude de phase I associant la rapamycine et l’irinotecan dans toutes tumeurs solides réfractaires de l’enfant (RAPIRI) Phase I clinical trial of rapamycine and irinotecan in pediatric patients with refractory solid tumors (RAPIRI)
assignment_turned_inProjectPartners:Centre Oscar Lambret, Centre Léon Bérard, CHU Marseille - Hôpital la Timone, Hôpital Femme-Enfant-Adolescent, Hôpital Hautepierre (CHRU) +2 partners
Centre Oscar Lambret,
Centre Léon Bérard,
CHU Marseille - Hôpital la Timone,
Hôpital Femme-Enfant-Adolescent,
Hôpital Hautepierre (CHRU),
Institut Gustave Roussy,
Institut Curie
Funder: Institut National du Cancer Project Code: INCa-DGOS-2486
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
more_vert
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
Randomised phase III study .Prospective trial for the diagnosis and treatment of children, adolescents and young adults with intracranial ependymoma
assignment_turned_inProjectPartners:CHU Dijon-Bourgogne - Centre Hospitalier Universitaire de Dijon, Hôpital Femme-Enfant-Adolescent, Hôpital Saint-Jacques, Institut Curie, Hôpital des Enfants +17 partners
CHU Dijon-Bourgogne - Centre Hospitalier Universitaire de Dijon,
Hôpital Femme-Enfant-Adolescent,
Hôpital Saint-Jacques,
Institut Curie,
Hôpital des Enfants,
Hôpital Sud Anne de Bretagne,
Centre Oscar Lambret,
CHU Montpellier - Hôpital Arnaud de Villeneuve,
Centre Hospitalier Universitaire de Poitiers,
Hôpital Hautepierre (CHRU),
Centre Léon Bérard,
Centre Hospitalier Universitaire d'Angers,
Hôpital Hôtel-Dieu,
CHUG,
Institut de cancérologie Lucien Neuwirth,
Délégation à la Recherche et à lInnovation - CHU Angers,
Centre Hospitalier Universitaire de Brest,
CHU Marseille - Hôpital la Timone,
Hôpital Pellegrin,
CHU Reims - Hôpital de la Maison Blanche,
Hôpital de l'Archet,
CHUAP
Funder: Institut National du Cancer Project Code: INCa-DGOS-5507
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
more_vert
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu

chevron_left
1
2
chevron_right

Hôpital Femme-Enfant-Adolescent

Hôpital Femme-Enfant-Adolescent

9 Projects, page 1 of 2

Anti-infectious agent specificity of benign (MGUS) and malignant (myeloma) monoclonal gammopathies: a proof-of-principle study.

Immunotherapy with CD19ζ gene-modified EBV-specific CTLs after stem cell transplant in children with high-risk acute lymphoblastic leukaemia

CALL-FB 01 : Protocole Franco-Belge de traitement des Leucémies Aiguës Lymphoblastiques de l’Enfant et de l’Adolescent CALL-FB 01: Franco-Belgian protocol for the treatment of acute lymphoblastic leukaemia (ALL) in children and adolescents

Etude de phase I associant la rapamycine et l’irinotecan dans toutes tumeurs solides réfractaires de l’enfant (RAPIRI) Phase I clinical trial of rapamycine and irinotecan in pediatric patients with refractory solid tumors (RAPIRI)

Randomised phase III study .Prospective trial for the diagnosis and treatment of children, adolescents and young adults with intracranial ependymoma

Loading